EUVIMEDEUVIMED entdecken
LeitlinieStudienprotokollOpen Access

Guideline-Based Clinical Decision Support Framework for Multimorbidity: Protocol for a Formulation and Testing Study

Zijun Wang iD, Ling Wang iD, Bingyi Wang iD, Hongfeng He iD, Zhewei Li iD, Di Zhu iD, Jie Zhang iD, Huayu Zhang iD, Yaolong Chen iD, Janne Estill iD

JMIR Research Protocols · 2025

DOI: 10.2196/63339 ↗

Kurz gefasst

Leitlinie in der Zeitschrift JMIR Research Protocols, 2025. Verfasst von Zijun Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Research Unit of Evidence-Based Evaluation and Guidelines, Chinese Academy of Medical Sciences, School of Basic Medical Sciences, Lanzhou University,…. Hauptthemen laut MEDLINE: Multimorbidity, Decision Support Systems, Clinical, Practice Guidelines as Topic. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The burden of multimorbidity is increasing globally, which complicates the use of guidelines in clinical practice and health care: practitioners may need to increasingly refer to multiple guidelines with potentially conflicting recommendations.

Objective

We aim to develop a guideline-based decision support framework for the management of patients with multimorbidity to help clinicians efficiently evaluate, select, and adapt recommendations focusing on the different comorbidities and aspects of multimorbidity.

Methods

We will conduct the project using the following steps: (1) needs assessment (searching published literature and documents on guideline use in multimorbidity care through the study initiators, and assessing the necessity of developing a comprehensive decision-making framework focusing on multimorbidity in a broad sense), (2) establishing international working groups (a coordination team, an evidence support group, and a consensus group) by leveraging existing participants’ networks and inviting experts with relevant academic publications or activities, (3) conducting literature reviews of multimorbidity guidelines and original qualitative research involving interest-holders in multimorbidity care and/or guideline development to formulate an initial draft framework, (4) a consensus process including an expert survey and a consensus meeting, (5) formulating and releasing the final framework, and (6) testing the framework (collecting feedback through educating health professionals in different settings and applying the framework in practice to evaluate and improve it). We plan to complete the project within 3 years.

Results

The project has started in March 2024 and is due to conclude in June 2026. As of May 2025, we have finished the literature reviews and qualitative studies and are currently conducting the first round of the expert survey.

Conclusions

This framework will help clinicians from all levels of health care institutions to make decisions in the management of patients with multimorbidity based on the latest available evidence, and to reduce potential health risks to their patients. One limitation of this framework is that such a broad framework may not fully fit all disease combinations or realistic situations. To reduce the degree of inapplicability, after completion of the framework, we will continue to monitor its use with regular updates as needed. International Registered Report Identifier (IRRID) DERR1-10.2196/63339

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MultimorbidityDecision Support Systems, ClinicalPractice Guidelines as TopicHumansConsensus

Stichwörter der Autor:innen

burdenclinical decision supportcomorbidityconsensushealth careinapplicabilitymonitoringmultimorbidityprotocolsupport framework

Autor:innen und Institutionen

  • Research Unit of Evidence-Based Evaluation and Guidelines, Chinese Academy of Medical Sciences, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.
  • Key Laboratory of Evidence Based Medicine of Gansu Province, Lanzhou, China.
  • Institute of Health Data Science, Lanzhou University, Lanzhou, China.
  • Institute of Global Health, University of Geneva, Geneva, Switzerland.
  • School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • School of Public Health, Lanzhou University, Lanzhou, China.

ORCID-Profile: Zijun Wang, Ling Wang, Bingyi Wang, Hongfeng He, Zhewei Li, Di Zhu, Jie Zhang, Huayu Zhang, Yaolong Chen, Janne Estill

Zitieren

APA

Wang, Z., Wang, L., Wang, B., He, H., Li, Z., Zhu, D., Zhang, J., Zhang, H., Chen, Y., & Estill, J. (2025). Guideline-Based Clinical Decision Support Framework for Multimorbidity: Protocol for a Formulation and Testing Study. JMIR Research Protocols. https://doi.org/10.2196/63339

Vancouver

Wang Z, Wang L, Wang B, He H, Li Z, Zhu D, et al. Guideline-Based Clinical Decision Support Framework for Multimorbidity: Protocol for a Formulation and Testing Study. JMIR Research Protocols. 2025. doi:10.2196/63339

BibTeX
@article{Wang2025,
  author = {Wang, Zijun and Wang, Ling and Wang, Bingyi and He, Hongfeng and Li, Zhewei and Zhu, Di and Zhang, Jie and Zhang, Huayu and Chen, Yaolong and Estill, Janne},
  title = {Guideline-Based Clinical Decision Support Framework for Multimorbidity: Protocol for a Formulation and Testing Study},
  journal = {JMIR Research Protocols},
  year = {2025},
  doi = {10.2196/63339}
}
Kostenlos starten →